Emerald Acquisition’s MediciNova MNOV Stock Holding History

Emerald Acquisition’s Portfolio MNOV Stock Details MNOV Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2016 Q3	$195K	Buy	+26,020	New	+$175K	﹤0.01%	2697

Other funds holding MNOV

Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return

EWM

Essex Woodlands Management The Woodlands, Texas $251M AUM 13.72% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

BFA

BlackRock Fund Advisors San Francisco, California $542B AUM 18.13% 1-Year Est. Return

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

BIT

BlackRock Institutional Trust San Francisco, California $675B AUM 16.07% 1-Year Est. Return

Northern Trust Chicago, Illinois $757B AUM 28.64% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return

Dimensional Fund Advisors Austin, Texas $481B AUM 30.42% 1-Year Est. Return

Bank of New York Mellon New York $544B AUM 28.31% 1-Year Est. Return

Emerald Acquisition's MNOV Position: Q3 2016 in Review

Emerald Acquisition opened a new position in MediciNova (MNOV) in Q3 2016: 26,020 shares worth $195K. The stake represents ﹤0.01% of the portfolio and ranks #2697 among its holdings.

51 funds tracked by Wall St. Rank hold MNOV as of Q3 2016.

Emerald Acquisition held 26,020 shares of MediciNova worth $195K as of Q3 2016.
MediciNova was a new Emerald Acquisition position in Q3 2016.
MediciNova made up ﹤0.01% of Emerald Acquisition's portfolio in Q3 2016, its #2697 holding.
51 funds tracked by Wall St. Rank held MediciNova as of Q3 2016.

Based on Emerald Acquisition's 13F filing for Q3 2016, filed 9 Nov 2016.